{
  "trial_id": "NCT00784485",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "39 years old"
    },
    {
      "criterion": "History of asthma",
      "label": "met",
      "evidence": "3 years history of asthma, frequent cough, wheezing, and shortness of breath and chest tightness"
    },
    {
      "criterion": "Current treatment with ICS and LABA",
      "label": "met",
      "evidence": "Currently uses inhaled corticosteroid (ICS) and fluticasone 500 mcg/salmeterol 50 mcg, one puff twice daily"
    },
    {
      "criterion": "FEV1 greater than/equal to 60%",
      "label": "met",
      "evidence": "Spirometry was performed revealing a forced expiratory volume in the first second (FEV1) of 63% of the predicted"
    },
    {
      "criterion": "Positive skin test or in vitro response to perennial allergen",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Use of oral or parenteral steroids within 6 months",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Use of omalizumab within less than 12 months",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of asthma and is currently on ICS and LABA. FEV1 is greater than/equal to 60%. However, the patient's use of oral corticosteroids in the past week may be a concern.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT00784485",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}